Your browser doesn't support javascript.
loading
Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations.
Ortiz, Michael V; Gerdemann, Ulrike; Raju, Sandya Govinda; Henry, Dahlia; Smith, Steve; Rothenberg, S Michael; Cox, Michael C; Proust, Stéphanie; Bender, Julia Glade; Frazier, A Lindsay; Anderson, Peter; Pappo, Alberto S.
Afiliación
  • Ortiz MV; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Gerdemann U; Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Raju SG; Loxo Oncology, Stamford, CT.
  • Henry D; Loxo Oncology, Stamford, CT.
  • Smith S; Loxo Oncology, South San Francisco, CA.
  • Rothenberg SM; Loxo Oncology, Stamford, CT.
  • Cox MC; Loxo Oncology, South San Francisco, CA.
  • Proust S; Department of Pediatric Hemato-Oncology, Children's University Hospital, Angers, France.
  • Bender JG; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Frazier AL; Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Anderson P; Cleveland Clinic, Cleveland, OH.
  • Pappo AS; St Jude Children's Research Hospital, Memphis, TN.
JCO Precis Oncol ; 42020.
Article en En | MEDLINE | ID: mdl-32923911
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JCO Precis Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos